Xenglu 25mg Tablet 28s – High-Strength Empagliflozin for Superior Diabetes, Heart & Kidney Protection
Xenglu 25mg Tablet 28s – High-Strength Empagliflozin for Superior Diabetes, Heart & Kidney Protection
Xenglu 25mg Tablet 28s – High-Strength Empagliflozin for Superior Diabetes, Heart & Kidney Protection
Description
Xenglu 25mg Tablet 28s – Maximum-Dose SGLT2 Inhibitor for Advanced Glycemic & Cardio-Renal Benefits
Xenglu 25mg Tablet delivers the highest approved dose of empagliflozin 25mg, a breakthrough SGLT2 inhibitor that removes excess glucose through urine while providing powerful protection against heart failure, cardiovascular death, and diabetic kidney disease progression. This once-daily 28-tablet pack (full month supply) is ideal for adults with type 2 diabetes who need stronger glucose lowering, have established cardiovascular disease, or are at high risk of heart/kidney complications. Patients often experience noticeable weight loss, lower blood pressure, and significantly improved long-term outcomes with this proven therapy.
